2025 Non-Steroidal Anti-inflammatory Drugs Industry Trends Report: Long-Term Outlook Through 2034

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

How Large Will the Non-Steroidal Anti-inflammatory Drugs Market Size By 2025?
In recent years, the non-steroidal anti-inflammatory drugs market has seen robust growth. The market, which was worth $20.68 billion in 2024, is predicted to increase to $22.1 billion in 2025, showing a compound annual growth rate (CAGR) of 6.8%. Factors contributing to this growth during the historical period include chronic inflammatory diseases, postoperative pain management, sports injuries, over-the-counter availability, an aging population, and increased consumer awareness.

How Big Is the Non-Steroidal Anti-inflammatory Drugs Market Size Expected to Grow by 2029?
The market size for non-steroidal anti-inflammatory drugs is projected to experience significant growth in the forthcoming years. The market is expected to expand to $28.79 billion by 2029, registering a compound annual growth rate (CAGR) of 6.8%. This growth during the forecast period is largely driven by developments in pain management treatments, regulatory shifts, the adoption of telehealth, global health and wellness trends, competition from biosimilars, patient choices, and targeted medicine strategies. Key trends in this period include dominance of the over-the-counter (OTC) market, increased demand for cox-2 inhibitors, generics and market competition, and the incorporation of digital health technologies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/non-steroidal-anti-inflammatory-drugs-global-market-report

Which Key Market Drivers Powering Non-Steroidal Anti-inflammatory Drugs Market Expansion and Growth?
The increase in cases of chronic pain is anticipated to foster the expansion of the non-steroidal anti-inflammatory drugs market in the future. Chronic pain is a discomfort enduring more than six months. Non-steroidal anti-inflammatory drugs serve the purpose of managing injuries and chronic pain. As an illustration, a report from the CDC (Centers for Disease Control and Prevention), a US-based government agency, revealed in April 2022 that arthritis, affecting millions of Americans, is a frequent source of chronic pain. About one in four adults with arthritis, equivalent to 15 million people, suffer from intense joint pain related to arthritis. Hence, the escalating prevalence of chronic pain is contributing to the growth of the non-steroidal anti-inflammatory drugs market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8023&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Non-Steroidal Anti-inflammatory Drugs Market?
In the market for non-steroidal anti-inflammatory drugs, a primary trend is product advancement. The dominant firms in this sector are focusing on inventing new technological solutions. For instance, Endo International plc, a pharmaceutical firm headquartered in Ireland, initiated the distribution of ibuprofen-famotidine 800 mg/26.6 mg tablets in March 2024. These tablets amalgamate the pain-relieving and anti-inflammatory features of ibuprofen along with the gastric-protective effects of famotidine. This mix is engineered to provide pain relief while also reducing the chance of digestive side effects which can arise from the long-term usage of NSAIDs such as ibuprofen.

What Are the Emerging Segments in the Non-Steroidal Anti-inflammatory Drugs Market?
The non-steroidal anti-inflammatory drugs market covered in this report is segmented -

1) By Route Of Administration: Oral, Topical, Other Route Of Administration
2) By Disease Indication: Arthritis, Migraine, Ophthalmic Diseases, Other Disease Indications
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:
1) By Oral: Tablets, Capsules, Liquids Or Solutions
2) By Topical: Gels, Creams, Patches
3) By Other Route Of Administration: Injectable (Intravenous And Intramuscular), Suppositories

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8023&type=smp

Who Are the Global Leaders in the Non-Steroidal Anti-inflammatory Drugs Market?
Major companies operating in the non-steroidal anti-inflammatory drugs market are Pfizer Inc., Bayer AG, Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Assertio Therapeutics Inc., Iroko Pharmaceuticals Inc., Reckitt Benckiser Group PLC, Perrigo Company PLC, Hikma Pharmaceuticals Public Limited Company, Glenmark Pharmaceuticals Limited, Septodont, Aspen Pharmacare Holdings Limited, Sagent Pharmaceuticals Inc., Advanced Pharma Inc., Akorn Operating Company LLC, Alembic Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Lupin Limited, Cipla Limited, Zydus Cadila Healthcare Limited, Aurobindo Pharma Limited, Sanofi S.A., GlaxoSmithKline PLC, Horizon Therapeutics PLC, Zyla Life sciences, Novartis AG, Roche Holding AG, AbbVie Inc., Bristol-Myers Squibb Company

Which are the Top Profitable Regional Markets for the Non-Steroidal Anti-inflammatory Drugs Industry?
North America was the largest region in the non-steroidal anti-inflammatory drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the non-steroidal anti-inflammatory drugs market during the forecast period. The regions covered in the non-steroidal anti-inflammatory drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8023

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.